Literature DB >> 3155504

Some evidence for the in vivo functional activation of suppressor T cells in asymptomatic patients with hemophilia A receiving Factor VIII concentrates.

H Seki, K Taga, T Nagaoki, R Barot-Ciorbaru, T Miyawaki, N Taniguchi.   

Abstract

Of 14 asymptomatic hemophilia A patients receiving factor VIII concentrates, 11 severe hemophilia patients had an inverted T-helper/suppressor ratio but 3 moderate patients had a normal ratio. Most hemophilia patients showed poor lymphocyte proliferative responses to mitogens and diminished in vitro immunoglobulin-producing ability of lymphocytes. One important finding was that most patients were found to have increased numbers of Ia-like antigen-positive suppressor T cells, suggesting that circulation activated suppressor T cells. In addition, OKT8+ suppressor T cells from severe hemophilia patients showed strong suppressor activity on B-cell differentiation in a Nocardia delipidated cell mitogen-driven system, whereas those from normal age-matched controls showed no suppressor function. These results suggested that suppressor T cells in hemophilia patients treated with factors might be already activated in vivo by undetermined mechanisms, implying the presence of a peculiar immunoregulatory status in this disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155504     DOI: 10.1016/0090-1229(85)90004-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients.

Authors:  V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 2.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

3.  Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes.

Authors:  T Ohno; M Inaba; K Kuribayashi; T Masuda; T Kanoh; H Uchino
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

4.  Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).

Authors:  C R Horsburgh; K C Davis; U Hasiba; S H Weiss; J J Goedert; P Sarin; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

5.  Abnormal B cell response to T cell-independent polyclonal B cell activators in haemophilia A.

Authors:  J Kekow; H Plendl; W L Gross
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

6.  Defective IL-6 secretion in HIV-infected haemophilia patients.

Authors:  R Weimer; S Zipperle; V Daniel; R Zimmermann; G Opelz
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.